Anna Carter

960 total citations
24 papers, 410 citations indexed

About

Anna Carter is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Anna Carter has authored 24 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Anna Carter's work include Multiple Myeloma Research and Treatments (9 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Anna Carter is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Anna Carter collaborates with scholars based in Israel, United States and United Kingdom. Anna Carter's co-authors include I. Tatarsky, Mariusz Z. Ratajczak, Bogusław Machaliński, Janina Ratajczak, Wojciech Marlicz, Marcin Majka, Jake P. Mann, Irit Hocherman, Jiali Gao and Shai Linn and has published in prestigious journals such as Cancer, Journal of Hepatology and British Journal of Haematology.

In The Last Decade

Anna Carter

23 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Carter Israel 11 214 158 105 98 55 24 410
Susan R. Wiersma United States 13 260 1.2× 137 0.9× 75 0.7× 78 0.8× 73 1.3× 16 517
Chin-Yang Li United States 11 166 0.8× 82 0.5× 134 1.3× 139 1.4× 61 1.1× 14 579
R Spanedda Italy 13 290 1.4× 154 1.0× 97 0.9× 173 1.8× 64 1.2× 34 471
Pierre Hirsch France 15 294 1.4× 153 1.0× 158 1.5× 143 1.5× 53 1.0× 39 568
Hiromi Koiso Japan 12 152 0.7× 94 0.6× 110 1.0× 73 0.7× 128 2.3× 44 426
CM Niemeyer United States 9 346 1.6× 151 1.0× 136 1.3× 114 1.2× 81 1.5× 15 631
AD Elias United States 10 338 1.6× 97 0.6× 111 1.1× 281 2.9× 63 1.1× 19 556
M Gaspard France 11 173 0.8× 84 0.5× 38 0.4× 171 1.7× 78 1.4× 28 467
Katarina Riesner Germany 10 134 0.6× 120 0.8× 40 0.4× 55 0.6× 94 1.7× 31 357
J Sans-Sabrafén Spain 14 264 1.2× 178 1.1× 337 3.2× 52 0.5× 74 1.3× 51 556

Countries citing papers authored by Anna Carter

Since Specialization
Citations

This map shows the geographic impact of Anna Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Carter more than expected).

Fields of papers citing papers by Anna Carter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Carter. The network helps show where Anna Carter may publish in the future.

Co-authorship network of co-authors of Anna Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Carter. A scholar is included among the top collaborators of Anna Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Carter. Anna Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kachale, Fannie, Mary Mugambi, Getrude Ncube, et al.. (2022). Catalyzing action on HIV/SRH integration: lessons from Kenya, Malawi, and Zimbabwe to spur investment. Global Health Action. 15(1). 2029335–2029335. 4 indexed citations
2.
Holmes, Charles B., Nduku Kilonzo, Jinkou Zhao, et al.. (2021). Strengthening measurement and performance of HIV prevention programmes. The Lancet HIV. 8(5). e306–e310. 6 indexed citations
3.
Morrison, Michelle, Mary Mahy, Brian Rice, et al.. (2020). High variability in the measurement of HIV primary prevention activities and outcomes. Journal of the International AIDS Society. 23(12). e25645–e25645. 4 indexed citations
4.
Carter, Anna, et al.. (2018). The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: A rare condition that mimics NAFLD. Journal of Hepatology. 70(1). 142–150. 49 indexed citations
5.
McCandliss, Stephan R., et al.. (2017). Scattered light characterization of FORTIS. 5650. 44–44. 5 indexed citations
6.
Majka, Marcin, Janina Ratajczak, Bogusław Machaliński, et al.. (2000). Expression, regulation and function of AC133, a putative cell surface marker of primitive human haematopoietic cells.. PubMed. 38(2). 53–63. 28 indexed citations
7.
Ratajczak, Mariusz Z., Janina Ratajczak, Bogusław Machaliński, et al.. (1998). Role of vascular endothelial growth factor (VEGF) and placenta‐derived growth factor (PlGF) in regulating human haemopoietic cell growth. British Journal of Haematology. 103(4). 969–979. 75 indexed citations
8.
Ratajczak, Mariusz Z., Wojciech Marlicz, Janina Ratajczak, et al.. (1997). Effect of hepatocyte growth factor on early human haemopoietic cell development. British Journal of Haematology. 99(1). 228–236. 30 indexed citations
9.
Carter, Anna, et al.. (1996). Expression and role in growth regulation of tumour necrosis factor receptors p55 and p75 in acute myeloblastic leukaemia cells. British Journal of Haematology. 92(1). 116–126. 18 indexed citations
10.
Nakhoul, Farid, Jacob Green, Zaid Abassi, & Anna Carter. (1996). Tumor lysis syndrome induced by fludarabine monophosphate: a case report. European Journal Of Haematology. 56(4). 254–255. 11 indexed citations
11.
Berkowicz, Miriam, et al.. (1995). Postremission therapy with two different dose regimens of cytarabine in adults with acute myelogenous leukemia. Leukemia Research. 19(12). 893–897. 2 indexed citations
12.
13.
Carter, Anna, et al.. (1992). Effect of interleukin‐1, tumor necrosis factor‐α, and interferon‐α on the blast cells of acute myeloblastic leukemia. American Journal of Hematology. 40(4). 245–251. 18 indexed citations
14.
15.
Carter, Anna, Irit Hocherman, Shai Linn, Yoram Cohen, & I. Tatarsky. (1987). Prognostic significance of plasma cell morphology in multiple myeloma. Cancer. 60(5). 1060–1065. 53 indexed citations
16.
Merchav, Shoshana, et al.. (1987). Immunoglobulin synthesis in myelodysplastic syndromes: Normal B-cell and immunoregulatory T-cell functions. Clinical Immunology and Immunopathology. 42(2). 195–201. 6 indexed citations
17.
Aviram, Michael, Anna Carter, J.G. Brook, & I. Tatarsky. (1985). Chylomicronaemia in multiple myeloma. Scandinavian Journal of Haematology. 34(5). 436–441. 5 indexed citations
18.
Brenner, Benjamin, et al.. (1984). Pancoast’s Syndrome in Multiple Myeloma. Acta Haematologica. 71(5). 353–355. 3 indexed citations
19.
Levy, Yishai, et al.. (1984). Plasma cholesterol concentration and extra lipid band in monoclonal gammopathies. Postgraduate Medical Journal. 60(705). 449–453. 13 indexed citations
20.
Tatarsky, I., et al.. (1983). Detection of IgD ‘hidden’ lambda light chain. Journal of Immunological Methods. 60(1-2). 207–212.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan R. Wiersma Breakdown of academic impact, for papers by Chin-Yang Li Breakdown of academic impact, for papers by R Spanedda Breakdown of academic impact, for papers by Pierre Hirsch Breakdown of academic impact, for papers by Hiromi Koiso Breakdown of academic impact, for papers by CM Niemeyer Breakdown of academic impact, for papers by AD Elias Breakdown of academic impact, for papers by M Gaspard Breakdown of academic impact, for papers by Katarina Riesner Breakdown of academic impact, for papers by J Sans-Sabrafén
Rankless by CCL
2026